Session Coverage

Hollywood, FL (January 22, 2020) -- With reimbursement pushing an increase in outpatient procedures, the topic of office-based labs, or OBLs, was a hot one at the International Symposium of Endovascular Therapy (ISET) 2020. In a focused...

Tilo Kölbel, MD (German Aortic Centre, University Heart Centre Hamburg, Germany) questions the dogma that rejects the use of endovascular treatment of connective tissue disorders, during a session on the latest techniques for endovascular...

A novel endovascular strategy to target severe calcified occlusions, the so-called “pave-and-crack” technique, was the focus of a presentation by Manuela Matschuck, MD, from University Hospital Leipzig.

Results of the first European prospective, multicenter clinical study of the use of a proximal scallop endograft that accommodates the supraaortic trunks were presented by Jean-Marc Alsac, MD.

Robert Lookstein, MD (Icahn School of Medicine at Mount Sinai, New York City) presented 10-year findings of the LONG DES-BTK study of the use of drug-eluting stents (DES) in the treatment of BTK disease.

Peter Schneider, MD, discussed the latest investigational device exemption (IDE) study of the DETOUR System, dubbed the US IDE DETOUR II Clinical Trial, which is currently recruiting across 37 sites in the U.S., Germany, Poland, and Latvia.